Avience Biomedicals Ltd Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: | Medical Equipment/Supplies/Accessories |

BSE Share Price
Not Listed

Avience Biomedicals Ltd Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: | Medical Equipment/Supplies/Accessories |

DeciZen - make an informed investing decision on Avience Biomedicals

Based on:

DeciZen not available for IPO

10 Year X-Ray of Avience Biomedicals:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 21.4%20.6%30.4%31.6%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 10.210.916.328.90
Sales YoY Gr.-7.6%48.9%77.7%-
Adj EPS 2.72.4612.80
YoY Gr.--12.2%153.8%111.3%-
BVPS (₹) 10.612.418.551.10
Adj Net
Profit
0.70.825.1NAN
Cash Flow from Ops. -21.70.23.1-
Debt/CF from Ops. -1.31.533.44.4-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA41.7%77.7%
Adj EPS NANA67.6%111.3%
BVPSNANA69.1%176.5%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
25.722.839.138.60
Op. Profit
Mgn %
1213.119.526.6NAN
Net Profit
Mgn %
7.17.212.217.8NAN
Debt to
Equity
0.90.71.30.7-
Working Cap
Days
02012242050
Cash Conv.
Cycle
0130113900

Recent Performance Summary

Recent Performance Summary not available for IPO

Recent Performance Summary not available for IPO

Latest Financials - Avience Biomedicals Ltd.

Standalone Consolidated
TTM EPS (₹) - -
TTM Sales (₹ Cr.) - -
BVPS (₹.) - -
Reserves (₹ Cr.) - -
P/BV - -
PE - -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) -
Equity (₹ Cr.) -
Face Value (₹) -
Industry PE -

Management X-Ray of Avience Biomedicals:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Valuation of Avience Biomedicals - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Avience Biomedicals

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Sales10.1510.9216.2628.89
Operating Expenses 8.939.4913.0821.21
Manufacturing Costs0.140.130.080.12
Material Costs7.517.7810.6517.19
Employee Cost 0.490.691.022.05
Other Costs 0.790.901.331.86
Operating Profit 1.221.433.177.68
Operating Profit Margin (%) 12.0%13.1%19.5%26.6%
Other Income 00.010.380.65
Interest 0.160.270.440.64
Depreciation 0.090.200.440.73
Exceptional Items 0000
Profit Before Tax 0.970.962.686.96
Tax 0.250.180.691.77
Profit After Tax 0.720.781.995.19
PAT Margin (%) 7.1%7.2%12.3%18.0%
Adjusted EPS (₹)2.72.46.112.9
Dividend Payout Ratio (%)0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 2.794.086.0720.60
Share Capital 2.033.283.284.03
Reserves 0.760.792.7916.57
Minority Interest0000
Debt2.492.647.3513.46
Long Term Debt0.170.151.276.29
Short Term Debt2.322.496.087.17
Trade Payables0.231.274.195
Others Liabilities 0.582.048.014.54
Total Liabilities 6.1010.0225.6343.60

Fixed Assets

Gross Block1.272.837.5510.32
Accumulated Depreciation0.100.310.741.46
Net Fixed Assets 1.172.526.828.86
CWIP 000.034.62
Investments 005.735.73
Inventories1.473.547.868.14
Trade Receivables2.531.702.428.89
Cash Equivalents 0.020.400.204.75
Others Assets 0.911.862.572.61
Total Assets 6.1010.0225.6343.60

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -1.961.740.233.14
PBT 0.970.962.686.96
Adjustment 0.250.470.791.26
Changes in Working Capital -3.030.48-3.12-4.43
Tax Paid -0.16-0.17-0.12-0.65
Cash Flow From Investing Activity -0.89-1.94-4.12-8.16
Capex -0.87-1.69-3.94-7.88
Net Investments -0.02-0.25-0.20-0.28
Others 000.010
Cash Flow From Financing Activity 2.790.433.809.06
Net Proceeds from Shares 1.020.5003.60
Net Proceeds from Borrowing 0005.01
Interest Paid -0.15-0.24-0.35-0.56
Dividend Paid 0000
Others 1.910.174.151
Net Cash Flow -0.060.24-0.094.04

Finance Ratio

PARTICULARSMar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)25.7122.7939.3138.95
ROCE (%)21.3520.5530.3631.57
Asset Turnover Ratio1.661.360.910.83
PAT to CFO Conversion(x)-2.722.230.120.61
Working Capital Days
Receivable Days91714671
Inventory Days5384128101
Payable Days11359498

Avience Biomedicals Ltd Stock News

Avience Biomedicals Ltd FAQs

The current trading price of Avience Biomedicals on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Avience Biomedicals stood at ₹0.00.
The latest P/E ratio of Avience Biomedicals as of 31-Dec-1969 is 0.00.
The latest P/B ratio of Avience Biomedicals as of 31-Dec-1969 is 0.00.
The 52-week high of Avience Biomedicals is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Avience Biomedicals is ₹0.00 ( Cr.) .

About Avience Biomedicals Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×